Long noncoding RNAs and chromatin regulation in cocaine addiction
Long noncoding RNAs and chromatin regulation in cocaine addiction
批准号:
8724105
负责人:
Claes Robert Wahlestedt
金额:
$19.19万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2016-03-31
关键词:
AffectAnimalsAntisense OligonucleotidesAreaAttentionAttenuatedBehaviorBehavioralBrainBromodomainChromatinCocaineCocaine DependenceComplexDataDevelopmentDrug AddictionEnzymesEpigenetic ProcessFutureGene ExpressionGenesGenetic TranscriptionGenomicsHabitsHistonesImmunoprecipitationInjection of therapeutic agentIntakeIntravenousLaboratoriesLeadLysineMediatingMolecularNeurosciencesNucleus AccumbensPathway interactionsPharmaceutical PreparationsPlayProcessProtein BindingProtein InhibitionProteinsRNARNA-Protein InteractionReaderRecruitment ActivityRegulationResearchRewardsRibonucleoproteinsRoleSelf AdministrationSystemTestingTherapeutic InterventionTranscriptTranscriptional ActivationUntranslated RNAWorkaddictionanticancer researchcell typechromatin remodelingcocaine usedeep sequencingdrug of abusegene repressionhistone acetyltransferasehistone modificationinnovationneuroadaptationneuromechanismnovelnovel strategiesnovel therapeuticspreferenceprotein complexpublic health relevanceresearch studyresponsescaffold
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recent studies have implicated histone-modifying enzymes as key regulators of chromatin state that contribute to cocaine-mediated changes in gene expression, neuroadaptations and seeking behaviors. However, only a limited number of histone-modifying proteins have been studied in the context of addiction, and particularly lacking are studies of epigenetic 'reader' proteins called bromodomains. Of the histone- modifying enzymes implicated in addiction, several are known to form complexes with multiple proteins in order to epigenetically alter transcription, but the underlying mechanisms involved in these interactions remain poorly understood. Growing evidence suggests that cell-type specific long noncoding RNAs (lncRNAs) modulate the function of these epigenetic proteins and/or complexes by acting as scaffolds that help recruit these processes to specific genomic loci. Therefore, investigating the role of lncRNAs in reward-related brain areas offers a fundamentally new approach to identify novel epigenetic mechanisms involved in addiction. In this application we aim to identify novel histone-modifying proteins involved in cocaine intake and determine the interactions between cocaine-related epigenetic targets and lncRNAs that are altered following self-administration of cocaine. We hypothesize that development of cocaine self-administration habit, in part, results from a coordinated change in expression of select histone-modifying proteins and specific lncRNAs that work in concert to epigenetically alter gene transcription. To test this hypothesis, the following aims are proposed: Specific Aim 1: Test the hypothesis that intra-accumbal knockdown of bromodomain genes affects cocaine self-administration. Preliminary data collected from our laboratory indicates that specific bromodomain proteins play an important role in cocaine reward and are increased in the nucleus accumbens following cocaine self-administration. Aim 1 will test whether these bromodomains regulate cocaine self- administration under restricted and extended access conditions. Specific Aim 2: Test the hypothesis that unique long noncoding RNA - protein interactions occur in the nucleus accumbens following cocaine self- administration. Long noncoding RNAs are key regulators of chromatin state, but it is unclear how these transcripts interact with epigenetic proteins to contribute to drug dependence. These studies will identify novel interactions between lncRNAs and histone-modifying proteins in the nucleus accumbens and determine if these associations are altered following yoked, restricted and extended access to cocaine self-administration. By revealing novel epigenetic targets and unchartered epigenetic mechanisms implicated in cocaine intake, a better understanding of these systems may ultimately lead to new therapeutic avenues for cocaine addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antisense RNA Mediated Epigenetic Regulation of Brain Derived Neurotrophic Factor
-
批准号:8619672
-
项目类别:
-
资助金额:$33.13万
-
财政年份:2013
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse
-
批准号:8468158
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2012
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse
-
批准号:8462352
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2012
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse
-
批准号:8652971
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2012
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Comprehensive analysis of the FMR1 locus transcriptional landscape
-
批准号:8414858
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2010
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Comprehensive analysis of the FMR1 locus transcriptional landscape
-
批准号:8213696
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2010
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Comprehensive analysis of the FMR1 locus transcriptional landscape
-
批准号:8258038
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2010
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Comprehensive analysis of the FMR1 locus transcriptional landscape
-
批准号:8066450
-
项目类别:
-
资助金额:$15.17万
-
财政年份:2010
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Comprehensive analysis of the FMR1 locus transcriptional landscape
-
批准号:7884901
-
项目类别:
-
资助金额:$48.63万
-
财政年份:2010
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Comprehensive analysis of the FMR1 locus transcriptional landscape
-
批准号:8607595
-
项目类别:
-
资助金额:$37.87万
-
财政年份:2010
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease
-
批准号:8257788
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Noncoding RNAs as epigenomic modulators in Alzheimer's Disease
-
批准号:7852491
-
项目类别:
-
资助金额:$47.28万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease
-
批准号:7654491
-
项目类别:
-
资助金额:$42.55万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease
-
批准号:8214672
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Noncoding RNAs as epigenomic modulators in Alzheimer's Disease
-
批准号:8259563
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease
-
批准号:8029496
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Noncoding RNAs as epigenomic modulators in Alzheimer's Disease
-
批准号:7937982
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Discovery and development of nociceptin receptor ligands in alcohol dependence
-
批准号:7650596
-
项目类别:
-
资助金额:$48.44万
-
财政年份:2009
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Role of noncoding RNAs in schizophrenia
-
批准号:8305335
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2008
-
负责人:Claes Robert Wahlestedt
-
依托单位:
Role of noncoding RNAs in schizophrenia
-
批准号:8037018
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2008
-
负责人:Claes Robert Wahlestedt
-
依托单位:
海外基金